Efficacy and Safety of SOM3355 in Huntington's Disease Chorea
NCT03575676
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Huntington's Chorea
Interventions
DRUG:
SOM3355 100mg BID
DRUG:
SOM3355 200mg BID
DRUG:
Placebo BID
Sponsor
SOM Innovation Biotech SA